Latest news with #CDSS
Ammon
a day ago
- Health
- Ammon
NASA and Google test AI medical assistant for astronaut missions
Ammon News - NASA and Google are collaborating to test an AI-powered medical assistant designed to support astronauts on long-duration missions, where communication delays with Earth make real-time medical consultations impossible. NASA, which is committed to a new era of human spaceflight with its Artemis program, is working with Google to test a proof of concept for a Crew Medical Officer Digital Assistant (CMO‑DA), a type of Clinical Decision Support System (CDSS). The digital assistant would provide medical support to astronauts when operating beyond low Earth orbit, such as on missions to the moon and Mars, allowing crews to autonomously diagnose and treat symptoms. "Trained on spaceflight literature, the AI system uses cutting-edge natural language processing and machine learning techniques to safely provide real-time analyses of crew health and performance," Google representatives said in an Aug. 8 statement. According to the statement, early results indicate the possibility of reliable diagnoses based on reported symptoms. NASA and Google are now working with doctors to further test and refine the model. Deep-space missions, including to the moon or Mars, can involve communication delays — sometimes up to 45 minutes for light-time round-trip for the Red Planet — making real-time consultations impossible. And a speedy return to Earth is obviously not an option in such cases. An onboard AI assistant could therefore help bridge a critical gap. The technology could also be of use in remote and demanding environments here on Earth, where access to trained medical professionals is limited.
Time of India
4 days ago
- Business
- Time of India
California $725 stimulus payment hits today — could you be one of the families getting August 15 deposit?
California $725 stimulus payment August 2025 is being issued today under the Family First Economic Support Pilot, giving monthly financial relief to low-income families with young children. Eligible families must be registered in the program, meet income limits, and have children under 6. California is rolling out $725 stimulus payments starting today, August 15, 2025, as part of the Family First Economic Support Pilot (FFESP). If you live in Sacramento or elsewhere in California and wonder whether you qualify, here's everything you need to know about the August deposit, eligibility requirements, and how the payments are being distributed. Tired of too many ads? Remove Ads What the FFESP Program Offers Who Qualifies for the August 2025 Payment Tired of too many ads? Remove Ads Residency in California : Only state residents enrolled in the program qualify. : Only state residents enrolled in the program qualify. Households with young children : Typically children under 6 years old are considered for support. : Typically children are considered for support. Low-income status : Income thresholds are aligned with state poverty guidelines. Families must demonstrate eligibility through prior registration or automatic enrollment processes. : Income thresholds are aligned with state poverty guidelines. Families must demonstrate eligibility through prior registration or automatic enrollment processes. Program enrollment: Only families already registered with the FFESP program or approved through partner agencies will receive funds. How Payments Are Delivered Direct deposit to existing bank accounts to existing bank accounts Prepaid debit cards for households without banking access for households without banking access Checks mailed to the registered address Why This Matters: California $725 Stimulus Payment August 2025: Tired of too many ads? Remove Ads Residency: Must live in one of the following Sacramento ZIP codes: 95815, 95821, 95823, 95825, 95828, or 95838. Must live in one of the following Sacramento ZIP codes: 95815, 95821, 95823, 95825, 95828, or 95838. Family Structure: Parent or legal guardian of a child aged 0–5 living with you at least 50% of the time. Parent or legal guardian of a child aged 0–5 living with you at least 50% of the time. Income Level: Household income must be below 200% of the Federal Poverty Level. Household income must be below 200% of the Federal Poverty Level. Selection Process: 200 families selected through a lottery system. Start Date: August 15, 2025 August 15, 2025 Payment Methods: Direct deposit or mailed check, depending on the recipient's banking information. Financial counseling and budgeting assistance. Access to community resources and support groups. Monthly financial education webinars. How to Check Your Eligibility Today Log in to the FFESP online portal and check your status. Confirm personal and child information is up to date. Contact CDSS directly if you encounter any issues or delays. FAQs: California is rolling out $725 stimulus payments starting today, August 15, 2025, as part of the Family First Economic Support Pilot (FFESP). This program is designed to help low-income families with young children, providing monthly financial support to ease everyday you live in Sacramento or elsewhere in California and wonder whether you qualify, here's everything you need to know about the August deposit, eligibility requirements, and how the payments are being Family First Economic Support Pilot is not a one-off payment. Instead, it provides a consistent, monthly benefit intended to help families cover essential expenses like groceries, rent, childcare, and note that this program is part of California's broader commitment to child welfare and financial equity. In previous years, participating households reported that the monthly payments significantly eased budget pressure, particularly for single-parent households. According to a 2024 California Department of Social Services (CDSS) survey, nearly 78% of FFESP recipients said the funds directly helped with childcare for the FFESP payment is targeted. Not every family in California will automatically receive $725. Key criteria include:Financial experts emphasize that this targeted approach is designed to maximize impact for families most in need, rather than broad-based, untargeted cash today, August 15. Payment methods vary depending on registration:Recipients are encouraged to verify their enrollment status through the official FFESP portal or by contacting local CDSS offices. In previous distributions, delays often occurred due to outdated contact information, emphasizing the importance of keeping records decision to continue these monthly $725 payments is a clear response to the dual pressures of rising inflation and childcare costs. Experts suggest that for households earning near or below the state median income, this funding represents a meaningful portion of discretionary spending—sometimes up to 10% of a family's monthly the program has long-term social implications. By alleviating immediate financial stress, families can invest more in children's nutrition, early education, and overall well-being. Economists from UC Berkeley's Center for Social Policy (2024) highlighted that consistent cash assistance programs improve childhood development outcomes and reduce household financial First Economic Support Pilot (FFESP)$725 per month12 months (August 2025 – July 2026)$8,700 over the program periodLow-income families with children aged 0–5The $725 monthly payments are not considered taxable income and will not affect eligibility for other assistance FFESP is a one-year pilot program, with payments continuing monthly through July wondering if they will receive the August 2025 deposit should:Households that meet all criteria can expect to see funds reflected immediately for direct deposit recipients, while mailed checks and prepaid cards may take several business low-income families with children under 6 registered in are sent via direct deposit, prepaid card, or mailed check.
Yahoo
16-06-2025
- Business
- Yahoo
Clinical Decision Support System Markets, 2024-2025 & 2030: Disruptive Technologies, Market Dynamics, Innovative Business Models, Competitive Environment, Transformative Megatrends
Clinical Decision Support Systems (CDSS) are at the forefront of healthcare innovation, driven by AI and machine learning. Market growth is fueled by the need for efficiency and early diagnosis, with a revenue forecast of $10.75 billion in 2024 and a 7.6% CAGR through 2030. Emphasizing personalized care, the report outlines challenges and opportunities within the CDSS market, highlighting major players and strategic imperatives impacting industry dynamics. Dublin, June 16, 2025 (GLOBE NEWSWIRE) -- The "Clinical Decision Support System Market, Global, 2024-2030" report has been added to revenue estimate for the base year 2024 is $10.75 billion, with a CAGR of 7.6% for the study period from 2024 to 2030. This report provides an overview of the global CDSS market, offering a detailed analysis, including a revenue forecast, for each application segment, namely, decision evidence/protocols, decision workflow, decision analytics, and decision delivery. The report also examines the factors driving and restraining this market and identifies the opportunities emerging from the changes in this space for market players and stakeholders to leverage. The base year is 2024, and the forecast period is from 2025 to increasing focus on effective population health management is prompting healthcare organizations to adopt next-generation clinical decision support tools that drive market growth. Healthcare systems continue to face significant clinical quality and efficiency challenges, leading to a heightened focus on implementing clinical decision support systems (CDSS). These tools facilitate early diagnosis and timely, precise clinical interventions in both hospital and home-based healthcare settings. They also help prevent complications in patient conditions, thereby reducing the need for costly interventions such as hospital readmissions and ICU admissions. Technological advancements in artificial intelligence (AI) and machine learning, including generative AI and conversational AI, are boosting ongoing innovation in CDSS solutions. The Impact of the Top 3 Strategic Imperatives on the CDSS Industry Disruptive Technologies Why: The CDSS has witnessed significant advancements with the development and integration of new technologies such as AI, cloud, predictive analytics, and mobile platforms, and it will continue to impact CDSS workflows in the next few years. To achieve a highly accessible, flexible, and scalable CDSS solution, end users will continue to look for technology Publisher's Perspective: Companies need to identify new use cases and build a strong foundation of evidence-based content. The integration of dynamic AI, specifically, a combination of conversational AI and generative AI (GenAI), can empower end users with easy access to relevant information, enabling them to, for instance, create documents for administrative Business Models Why: A high upfront installation and implementation cost has restrained the widespread adoption of CDSS solutions. CDSS has significant potential to improve healthcare outcomes with better clinical recommendations, ultimately benefiting patients and providers in terms of cost and resource Publisher's Perspective: Evolving business models such as software-as-a-service (SaaS), subscription models, and risk-based incentives created by technology vendors can provide flexibility in upfront investment and boost CDSS adoption. Growing awareness about the long-term benefits of improved health outcomes and economic growth will drive CDSS growth in the next few Megatrends Why: Medical errors and staff burnout affect healthcare systems' ability to provide optimal patient care. Transitions to home care, a focus on value-based care, an increasing number of data sources, revisions of guidelines, and revenue losses also present significant challenges. Moreover, growing healthcare consumerism and a shift towards personalized care exhaust stakeholders in the face of critical decision-making moments. This is where CDSS has the biggest Publisher's Perspective: This evolving market demands that vendors regularly update their products and features. Expanding offerings is critical to remaining a viable player. However, such developments cannot happen in isolation. Vendors need to include key end users and decision-makers in their research and development (R&D) programs to best target their investments toward those stakeholders' pain points. To stay ahead of the competition, companies must utilize both organic and inorganic growth pathways. Competitive Environment Growing Demand for Personalized Medicine: Personalized medicine, which involves tailoring medical treatment to individual patients based on their unique characteristics, is gaining traction. CDSS can play a crucial role in facilitating personalized medicine by integrating patient-specific data, genetic information, and clinical guidelines to provide tailored recommendations. This growing demand for personalized medicine is a significant Healthcare Costs and Resource Constraints: Healthcare systems worldwide are facing increasing financial pressures and resource constraints. CDSS can help optimize resource utilization by providing real-time clinical insights, reducing unnecessary tests and procedures, and improving overall efficiency. This cost-effectiveness aspect is a significant driver for the adoption of CDSS Restraints Cost and Budgetary Constraints: Implementing and maintaining CDSS software can be costly, especially for smaller healthcare organizations or those with limited budgets. The investments in hardware, software licenses, infrastructure upgrades, and ongoing maintenance and support costs can be significant. Budgetary constraints may deter healthcare providers from adopting CDSS, especially if they perceive the benefits as uncertain or difficult to Acceptance and Alert Fatigue: Clinicians may be skeptical of automated systems' accuracy or be concerned about a loss of autonomy. Moreover, too many or unimportant alerts may lead to alert fatigue among physicians, affecting the usage of Integration Complexities: Variations in standards for healthcare records can present challenges in effective CDSS integration with existing hospital IT systems. Scope of Analysis Clinical decision support (CDS) provides clinicians and healthcare staff with knowledge and person-specific information that helps them improve clinical decisions and enhance patient healthcare. A clinical decision support system (CDSS) is a broad concept with many definitions that are used variably. It encompasses a variety of tools to enhance decision-making in the clinical workflow. CDSS includes a mix of evidence (content), analytics, workflow, devices, and software-based solutions that consist of the electronic health record (EHR) and are maintained by an IT platform. This report delivers a detailed analysis of the CDSS market and its applications, specifically, decision evidence/protocols, decision workflow, decision analytics, and decision delivery. The report analyzes industry challenges, drivers, and restraints, and offers a revenue forecast for each application area. It covers important business models, the regulatory outlook, cost structures, and the competitive landscape. Description of the top growth opportunities for the global CDSS market in the context of user relevance and calls to action has also been provided. The revenue estimates in this study focus only on revenue attributed to CDSS. In some cases, such as analytics, electronic health records, and device companies, CDSS revenue represents a small part of a larger revenue stream. Key Competitors Optum EBSCO Elsevier Hearst Health Merative Medicomp Systems Wolters Kluwer RethinkFirst Glass Health UNORK Premier Inc. (STANTON HEALTH) Getinge Motive Medical Intelligence athenahealth EvidenceCare HCA Healthcare MEDITECH eClinicalWorks Wolters Kluwer RIMIDI Inovalon Vizio Flatiron Health (Roche) Medecision MCG Health Epic Medical Informatics Corp. Medtronic Oracle Health Philips Healthcare GE Healthcare Stat Pearls Key Topics Covered: Growth Opportunities: Research Scope Scope of Analysis Segmentation by Application Segmentation by Region Key Vendor Types Growth Environment: Transformation in CDSS Why Is It Increasingly Difficult to Grow? The Strategic Imperative 8 The Impact of the Top 3 Strategic Imperatives on the CDSS Industry Ecosystem in CDSS Competitive Environment Key Competitors Growth Generators in CDSS Evolution of CDSS Key Use Cases Key Market Trends Key Challenges and Value Proposition Voice of Consumers: AI Integration in CDSS Potential GenAI Use Cases in CDSS Vendor Value Propositions with AI Regulatory Scenario: FDA's Approach to CDSS Growth Metrics Growth Drivers Growth Restraints Forecast Considerations Revenue Forecast Revenue Forecast by Application Revenue Forecast Analysis Pricing Trends and Forecast Analysis Revenue Forecast by Region Analysis of CDSS Solution Attractiveness Regional Attractiveness Ranking and Mapping Revenue Forecast Analysis by Region Revenue Share Competitive Heatmap Revenue Share Competitive Heatmap Analysis Company Spotlight Growth Generator: Decision Evidence/Protocols Growth Metrics Revenue Forecast Revenue Forecast by Region Forecast Analysis Growth Generator: Decision Analytics Growth Metrics Revenue Forecast Revenue Forecast by Region Forecast Analysis Growth Generator: Decision Workflow Growth Metrics Revenue Forecast Revenue Forecast by Region Forecast Analysis Growth Generator: Decision Delivery Growth Metrics Revenue Forecast Revenue Forecast by Region Forecast Analysis Growth Opportunity Universe Growth Opportunity 1: AI in CDSS Growth Opportunity 2: Real-time data for Critical Conditions Growth Opportunity 3: Point-of-care CDSS for Home-based Treatment Appendix and Next Steps Benefits and Impacts of Growth Opportunities Next Steps For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Business Wire
04-06-2025
- Business
- Business Wire
Wolters Kluwer Again Recognized as Clinical Decision Support Leader
WALTHAM, Mass.--(BUSINESS WIRE)-- Wolters Kluwer Health has once again been identified as one of the top two companies in the new Frost Radar™ report on Clinical Decision Support Systems (CDSS). Evaluating over 60 companies, the Frost Radar spotlights 10; Wolters Kluwer was the only one named both a 'Company to Action' and the market leader for innovation. The company was also a leader in the 2023 report. Wolters Kluwer Health has been identified as one of the top two companies in the new Frost Radar™ report on Clinical Decision Support Systems (CDSS) and the only one named both a 'Company to Action' and the market leader for innovation. Share According to the Frost report, the top-right Radar position of Wolters Kluwer shows it 'has firmly established itself as a leader in the CDSS market, with impressive R&D investment, and recent and upcoming product launches. The company's strategic integration of emerging technologies, particularly Gen AI, has positioned it at the forefront of next-generation CDSS solutions.' The report also recognizes the company's redefinition of the CDSS category with its introduction of UpToDate Enterprise Edition stating it 'is designed to align buyers, administrators, and care teams on a singular platform. This strategic alignment is key in enhancing care delivery and realizing superior returns on investment. With advanced on-demand analytics, this edition offers system-level insights into product usage, community trends, education needs, and the overarching impact of UpToDate on healthcare systems.' 'The Frost Radar is a deep dive into the CDSS market and its vendors. Based on our analysis, Wolters Kluwer has achieved significant growth for its solutions by focusing on innovation and customer-centric solutions,' said Dr. Rishi Pathak, Global Director of Healthcare & Life Sciences, Frost & Sullivan. 'That, combined with their strategy to increase the reach of UpToDate through integration into the clinician workflow and the intention to address adjacent operational and financial workflows, puts them in the leadership position.' Wolters Kluwer Health recently announced the integration of UpToDate with several ambient AI leaders, including Abridge, Suki, Microsoft and others. 'Being named the innovation leader in the Frost Radar reinforces our focus on innovation and interconnectivity and validates our commitment to transforming healthcare through product innovation and strategic partnerships,' said Greg Samios, CEO of Wolters Kluwer Health. 'We remain dedicated to helping providers make faster, smarter decisions across the care continuum, while enabling organizations to maximize their UpToDate investment through insightful analytics, harmonized content, seamless integration, and AI-enhanced features.' Learn more about Wolters Kluwer in the Frost Radar on CDSS. About Wolters Kluwer Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services. Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. For more information, visit follow us on LinkedIn, Facebook, YouTube and Instagram.
Yahoo
20-05-2025
- Business
- Yahoo
Clinical Decision Support Systems (CDSS) Market worth US$3.89 billion by 2030 with 9.6% CAGR
DELRAY BEACH, Fla., May 20, 2025 /PRNewswire/ -- The global clinical decision support systems market , valued at US$2.25 billion in 2024, is forecasted to grow at a robust CAGR of 9.6%, reaching US$2.46 billion in 2025 and an impressive US$3.89 billion by 2030. The rising adoption of healthcare IT solutions, increasing demand for better clinical outcomes, and concerns over medication errors and patient safety are driving the growth of CDSS. Advancements in AI, machine learning, and natural language processing are improving the accuracy and efficiency of CDSS tools, while government initiatives, widespread EHR use, and investments in digital health infrastructure are further fueling market expansion worldwide. Download PDF Brochure: Browse in-depth TOC on "Clinical Decision Support Systems Market" 300 - Tables 55 - Figures 350 - Pages By delivery mode, the clinical decision support systems market is divided into on-premises and cloud-based modes. In 2024, the on-premises CDSS segment is estimated to account for the largest share of the clinical decision support systems market. This growth of this segment is primarily due to the growing demand for data security and control, especially among large healthcare organizations and multispecialty hospitals. On-premises solutions offer enhanced data protection, allowing institutions to manage patient information within their infrastructure, thereby reducing the risk of data breaches. These systems provide organizations with the flexibility to customize and integrate CDSS with existing healthcare systems and workflows, catering to specific organizational needs. The ability to decide when to implement software upgrades ensures that institutions have adequate time to test new features and train staff, minimizing disruptions to clinical operations. By interactivity level, the clinical decision support systems market can be divided into active CDSS and passive CDSS. In 2024, the active CDSS is the fastest-growing segment during the forecast period. Active CDSS provides real-time alerts and recommendations directly within clinical workflows, enhancing decision-making efficiency and patient safety. Robust government initiatives promoting the adoption of healthcare IT solutions, such as electronic health records (EHRs), CDSS, and computerized provider order entry (CPOE), are significantly contributing to this growth. For instance, the US Department of Health and Human Services revised certification program rules in April 2023 to encourage greater utilization of clinical decision support tools. By geography, The Asia Pacific region is expected to experience significant growth, with a noticeable annual growth rate during the forecast period. Key factors driving the expansion of clinical decision support systems solutions in this region include rising healthcare expenditure, growing awareness about the benefits of health IT, and expanding digital infrastructure. Rapid urbanization and increasing prevalence of chronic diseases are placing pressure on healthcare systems, prompting investments in advanced clinical technologies such as CDSS to improve efficiency and patient outcomes. Government initiatives promoting digital health, such as India's Ayushman Bharat Digital Mission and China's Health Information System reforms, are accelerating the adoption of EHRs and CDSS platforms. The growing presence of multinational healthcare IT firms, increasing collaborations with local providers, and a rising demand for cost-effective healthcare solutions are all contributing to the region's rapid market expansion. Request Sample Pages : Wolters Kluwer N.V. (Netherlands), Oracle (US), Merative (US), Change Healthcare (US), Veradigm Inc. (US), athenahealth (US), Epic Systems Corporation (US), Elsevier B.V. (Netherlands), Zynx Health (US), Koninklijke Philips N.V. (Netherlands), Medical Information Technology, Inc. (US), NextGen Healthcare, Inc. (US), CureMD Healthcare (US), Siemens Healthineers (Germany), EBSCO Information Services (US), GE HealthCare (US), eClinicalWorks (US), The Medical Algorithms Company (UK), RAMPmedical (Germany), Hera-MI (France), CareCloud, Inc. (US), VisualDx (US), Premier, Inc. (US), First Databank, Inc. (US), and Strata Decision Technology (US) are the major players in this market. These companies are mainly focusing on strategies such as acquisitions, collaborations, partnerships, expansion, and product launches and updates to remain competitive and further increase their share in the market. Wolters Kluwer N.V. (Netherlands) Wolters Kluwer N.V. provides comprehensive healthcare solutions, specializing in clinical decision support systems (CDSS). The company offers drug information software, point-of-care tools, bibliographic databases, and online education products that aid healthcare delivery. Its core strength lies in evidence-based, physician-authored clinical decision support resources, which enhance clinical effectiveness, patient safety, and decision-making. UpToDate, its flagship CDSS, is trusted by healthcare professionals for evidence-based insights that improve patient outcomes. Its healthcare portfolio covers clinical drug information, patient engagement, medical research, and nursing solutions, with a focus on continuous learning and safety. Wolters Kluwer operates in over 180 countries and employs approximately 21,400 professionals, delivering advanced solutions that improve healthcare practices and research worldwide. Oracle (US): Oracle provides healthcare information technology (HCIT) solutions, offering services that support clinical, financial, and operational functions across healthcare organizations. In June 2022, Oracle acquired Cerner, forming Oracle Cerner, a wholly owned subsidiary focused on improving patient care and population health management. Oracle Cerner delivers a connected clinical and financial ecosystem supported by offerings across cloud, licensing, hardware, and services. It operates globally across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, with strong supplier relationships ensuring a resilient supply chain. The company has advanced its cloud-based clinical decision support systems (CDSS) by integrating them into Electronic Health Records (EHRs) to enhance early cancer detection. These tools use machine learning to analyze patient data, helping clinicians identify cancer risks more accurately and efficiently, thereby improving oncology decision-making at the point of care. Merative (US) Merative formerly IBM Watson Health, is a key provider in the clinical decision support systems (CDSS) market. After becoming an independent entity under Francisco Partners in 2022, Merative has continued to deliver healthcare solutions across domains such as clinical decision support, healthcare analytics, enterprise imaging, and real-world evidence. Its CDSS tools equip physicians, nurses, and pharmacists with real-time, evidence-based insights at the point of care. According to the blog published by Merative in April 2024, the company emphasized the strategic value of CDSS investments for hospital leadership, urging a focus on evidence-based interventions to prevent medication errors, medication validation at scale to reduce cost and wastage, and streamlined access to information to support clinical efficiency and reduce burnout. For more information, Inquire Now! Related Reports: Healthcare IT Market Biomarkers Market Healthcare Cloud Computing Market Point of Care Diagnostics Market Healthcare Analytics Market Get access to the latest updates on Clinical Decision Support Systems Companies and Clinical Decision Support Systems Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content to download multimedia: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
